We used an approach combining expression profiling of three different tumor cell lines, reflecting the typical genetic background of primary colorectal cancers, and pathway interference by inhibitors targeting different elements of the RTK/RAS/MEK/ERK signal cascade (Figure 1). Here, MAP2K7 is linked to colorectal cancer.